Accumulating evidence has suggested that impaired activity of SOD2 and SOD3 contributed to pulmonary hypertension, and the level and activity of SOD1 has not been found significantly changed in human pulmonary hypertension [34, 35]. This evidence concerns the gene SOD1 and pulmonary arterial hypertension.